IDENTIFICATION OF THE MEMBRANE GLYCOPROTEIN THAT IS THE C3B RECEPTOR OF THE HUMAN ERYTHROCYTE, POLYMORPHONUCLEAR LEUKOCYTE, B LYMPHOCYTE, AND MONOCYTEFEARON DT.1980; J. EXPER. MED.; USA; DA. 1980; VOL. 152; NO 1; PP. 20-30; BIBL. 38 REF.Article

PURIFICATION OF C3B INACTIVATION AND DEMONSTRATION OF ITS TWO POLYPEPTIDE CHAIN STRUCTURE.FEARON DT.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 4; PP. 1248-1252; BIBL. 23 REF.Article

REGULATION OF THE AMPLIFICATION C3 CONVERTASE OF HUMAN COMPLEMENT BY AN INHIBITORY PROTEIN ISOLATED FROM HUMAN ERYTHROCYTE MEMBRANEFEARON DT.1979; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1979; VOL. 76; NO 11; PP. 5867-5871; BIBL. 29 REF.Article

REGULATION BY MEMBRANE SIALIC ACID OF BETA 1H-DEPENDENT DECAY-DISSOCIATION OF AMPLIFICATION C3 CONVERTASE OF THE ALTERNATIVE COMPLEMENT PATHWAY.FEARON DT.1978; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1978; VOL. 75; NO 4; PP. 1971-1975; BIBL. 47 REF.Article

ENDOCYTOSIS OF THE C3B RECEPTOR OF COMPLEMENT WITHIN COATED PITS IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTESABRAHAMSON DR; FEARON DT.1983; LABORATORY INVESTIGATION; ISSN 0023-6837; USA; DA. 1983; VOL. 48; NO 2; PP. 162-168; BIBL. 32 REF.Article

ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS.FEARON DT; AUSTEN KF.1977; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1977; VOL. 74; NO 4; PP. 1683-1687; BIBL. 33 REF.Article

PROPERDIN: BINDING TO C3B AND STABILIZATION OF THE C3B-DEPENDENT C3 CONVERTASE.FEARON DT; AUSTEN KF.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 142; NO 4; PP. 856-863; BIBL. 1 P.Article

CURRENT CONCEPTS IN IMMUNOLOGY: THE ALTERNATIVE PATHWAY OF COMPLEMENT; A SYSTEM FOR HOST RESISTANCE TO MICROBIAL INFECTIONFEARON DT; AUSTEN KF.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 303; NO 5; PP. 259-263; BIBL. 34 REF.Article

INITIATION OF C3 CLEAVAGE IN THE ALTERNATIVE COMPLEMENT PATHWAY.FEARON DT; AUSTEN KF.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 115; NO 5; PP. 1357-1361; BIBL. 23 REF.Article

PROPERDIN: INITIATION OF ALTERNATIVE COMPLEMENT PATHWAY.FEARON DT; AUSTEN KF.1975; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1975; VOL. 72; NO 8; PP. 3220-3224; BIBL. 27 REF.Article

ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY WITH RABBIT ERYTHROCYTES BY CIRCUMVENTION OF THE REGULATORY ACTION OF ENDOGENOUS CONTROL PROTEINS.FEARON DT; AUSTEN KF.1977; J. EXPER. MED.; U.S.A.; DA. 1977; VOL. 146; NO 1; PP. 22-33; BIBL. 2 P. 1/2Article

INHIBITION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY GOLD SODIUM THIOMALATE IN VITRO.BURGE JJ; FEARON DT; AUSTEN KF et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 5; PP. 1625-1630; BIBL. 1 P. 1/2Article

AUTOSOMAL LOCUS REGULATES INVERSE RELATIONSHIP BETWEEN SIALIC ACID CONTENT AND CAPACITY OF MOUSE ERYTHROCYTES TO ACTIVATE HUMAN ALTERNATIVE COMPLEMENT PATHWAYNYDEGGER UE; FEARON DT; AUSTEN KE et al.1978; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1978; VOL. 75; NO 12; PP. 6078-6082; BIBL. 37 REF.Article

CLINICAL AND BIOCHEMICAL EFFECTS OF STANOZOLOL THERAPY FOR HEREDITARY ANGIOEDEMASHEFFER AL; FEARON DT; AUSTEN KF et al.1981; J. ALLERGY CLIN. IMMUNOL.; ISSN 0091-6749; USA; DA. 1981; VOL. 68; NO 3; PP. 181-187; BIBL. 23 REF.Article

LA VOIE ALTERNE DU COMPLEMENTKAZATCHKINE M; NYDEGGER U; FEARON DT et al.1979; NOUV. PRESSE MED.; FRA; DA. 1979; VOL. 8; NO 26; PP. 2187-2194; ABS. ENG; BIBL. 75 REF.Article

HETEROGENEITY, POLYPEPTIDE CHAIN COMPOSITION AND ANTIGENIC REACTIVITY OF C3 NEPHRITIC FACTOR.DAHA MR; AUSTEN KF; FEARON DT et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 4; PP. 1389-1395; BIBL. 22 REF.Article

MEMBRANE SIALIC ACID ON TARGET PARTICLES MODULATES THEIR PHAGOCYTOSIS BY A TRYPSIN-SENSITIVE MECHANISM ON HUMAN MONOCYTES.CZOP JK; FEARON DT; AUSTEN KF et al.1978; PROC. NATION. ACAD. SCI. USA; USA; DA. 1978; VOL. 75; NO 8; PP. 3831-3835; BIBL. 23 REF.Article

CLINICAL AND BIOCHEMICAL EFFECTS OF IMPEDED ANDROGEN (OXYMETHOLONE) THERAPY OF HEREDITARY ANGIOEDEMASHEFFER AL; FEARON DT; AUSTEN KF et al.1979; J. ALLERGY CLIN. IMMUNOL.; USA; DA. 1979; VOL. 64; NO 4; PP. 275-280; BIBL. 14 REF.Article

THE MODULATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT IN C2-DEFICIENT HUMAN SERUM BY CHANGES IN CONCENTRATION OF THE COMPONENT AND CONTROL PROTEINS.NYDEGGER UE; FEARON DT; AUSTEN KF et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 4; PP. 1404-1408; BIBL. 27 REF.Article

ISOLATION OF ALTERNATIVE PATHWAY C3 CONVERTASE CONTAINING UNCLEAVED B AND FORMED IN THE PRESENCE OF C3 NEPHRITIC FACTOR (C3NEF) = ISOLEMENT D'UNE C₃ CONVERTASE DE LA VOIE ALTERNEE CONTENANT DU B NON CLIVE ET FORMEE EN PRESENCE DU FACTEUR C₃ NEPHRITIQUE (C3NEF)DAHA MR; FEARON DT; AUSTEN KF et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 116; NO 2; PP. 568-570; BIBL. 16 REF.Article

INHIBITION OF THE ALTERNATIVE PATHWAY OF HUMAN COMPLEMENT IN VITRO BY A NATURAL MICROBIAL PRODUCT, COMPLESTATINKANEKO I; FEARON DT; AUSTEN KF et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 3; PP. 1194-1198; BIBL. 23 REF.Article

OPSONIN-INDEPENDENT PHAGOCYTOSIS OF ACTIVATORS OF THE ALTERNATIVE COMPLEMENT PATHWAY BY HUMAN MONOCYTES.CZOP JK; FEARON DT; AUSTEN KF et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 4; PP. 1132-1138; BIBL. 22 REF.Article

METHYLTESTOSTERONE THERAPY IN HEREDITARY ANGIOEDEMA.SHEFFER AL; FEARON DT; AUSTEN KF et al.1977; ANN. INTERN. MED.; U.S.A.; DA. 1977; VOL. 86; NO 3; PP. 306-308; BIBL. 23 REF.Article

THE INCORPORATION OF C3 NEPHRITIC FACTOR (C3NEF) INTO A STABILIZED C3 CONVERTASE, C3BBB (C3NEF), AND ITS RELEASE AFTER DECAY OF CONVERTASE FUNCTION.DAHA MR; AUSTEN KF; FEARON DT et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 812-817; BIBL. 19 REF.Article

C3 NEPHRITIC FACTOR (C3NEF): STABILIZATION OF FLUID PHASE AND CELL-BOUND ALTERNATIVE PATHWAY CONVERTASEDAHA MR; FEARON DT; AUSTEN KF et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 116; NO 1; PP. 1-7; BIBL. 29 REF.Article